RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) today and set a price target of $75.00. The ...

Here, the plaintiff has alleged that a core principle of being 'Pagan' is submitting to natural forces and refusing ...

(Reuters) -British drugmaker GSK announced on Thursday positive results from a mid-stage trial of its seasonal influenza ...

The study investigates COVID-19 vaccine-related myocarditis in adolescents, revealing clinical characteristics and risks of ...

Aerosolized mucosal vaccines show promise in controlling SARS-CoV-2, offering greater protection and immune response than ...

The Food and Drug Administration approved an updated coronavirus vaccine manufactured by Novavax Friday, days after new mRNA coronavirus vaccines manufactured by Pfizer-BioNTech and Moderna ...

Is MRNA stock a sell? These biotech stocks have what it takes to be the biggest winners through the rest of the decade and beyond. Moderna shares surged Tuesday after Canadian regulators approved ...

An experimental Moderna mRNA vaccine for mpox has demonstrated greater effectiveness than current shots in reducing disease ...

With donor livers in short supply, they think mRNA could one day provide an alternative to transplants. The team plans to begin a clinical trial next year to test the idea in people with end-stage ...

Developed by Moderna Pharmaceuticals-the same company that made headlines with its Covid-19 vaccine-the jab, known as mRNA-4359, is designed to activate the body's immune system to identify and ...

Moderna uses the same mRNA technology in its highly safe and effective coronavirus vaccine. In the study, six macaques were vaccinated with the mRNA vaccine, and another six received an equivalent ...